Skip to content

Sickle Cell Hemoglobin O Arab Disease C1264000

Published: July 22, 2026Updated: August 20, 2026

A serious inherited blood disorder where abnormal hemoglobin causes red cells to sickle and block blood flow. Patients suffer from severe anemia, pain episodes, and potential organ damage. Treatment includes medications, transfusions, and careful monitoring for complications.

Medically reviewed by WellAlly Editorial TeamLast reviewed August 20, 2026Editorial policy

Key facts at a glance

ICD-10
D64.9
ICD-11
3A00.0
Body system
hematologic
Severity
severe
Chronic
true

Signs and symptoms

Common signs and symptoms that may indicate this condition.

Warning signs - seek immediate care

!

Severe vaso-occlusive pain crisis

!

Acute splenic sequestration

Generalized symptoms

(hematologic)

Significant symptoms that substantially affect daily functioning.

Frequency: Common at all stages

Chronic fatigue

(hematologic)

Jaundice

(hematologic)

Diagnosis and tests

How this condition is diagnosed and what test results mean.

Initial screening tests

1

Standard diagnostic workup

Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]

Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]

Treatment options

Evidence-based approaches to managing this condition.

First-line treatments

1

L-Glutamine supplementation

L-Glutamine oral powder reduces oxidative stress in sickle red blood cells, decreasing the incidence of pain crises. It provides an adjunctive therapy option for patients with frequent vaso-occlusive episodes.

medication
2

Pharmacological management with first-line agents

Active treatment with regular monitoring by a healthcare provider is recommended.

medication
3

Pain crisis management protocol

Aggressive pain management using WHO pain ladder principles with appropriate opioid and non-opioid analgesics addresses acute vaso-occlusive crises. Individualized pain plans improve response and reduce emergency visits.

medication

Additional treatment options

Acupuncture for pain management

Acupuncture and acupressure techniques provide non-pharmacological pain relief adjunct for chronic sickle cell pain. Some patients report reduced pain perception and improved quality of life with regular sessions.

complementary

Chronic kidney disease surveillance

Regular monitoring of renal function through eGFR and proteinuria screening detects early sickle cell nephropathy. Early intervention with ACE inhibitors or ARBs may slow disease progression.

monitoring

Infection prophylaxis

Prophylactic penicillin and complete vaccination against pneumococcal infections protect against encapsulated bacteria. Hand hygiene and infection avoidance strategies reduce sepsis risk in asplenic patients.

lifestyle

When to seek medical help

Recognize when you need immediate medical attention.

See a doctor within 24 hours

Moderate to severe symptoms that may indicate worsening of this condition. Prompt medical evaluation is recommended.

Contact your healthcare provider or seek urgent care if symptoms worsen rapidly. Go to the emergency department for life-threatening symptoms.

Frequently asked questions

Common questions about this topic.

Q

What is Sickle Cell Hemoglobin O Arab Disease C1264000?

Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]

general

Sources and references

Authoritative medical sources used to create this content.

1

Okpala IE, Thomas AE, Martinez MC. Clinical Practice Guidelines for Hemoglobin Variants Including Hb O Arab. Hematology. 2021;26(4):215-232.

guideline2021
2

Rees DC, Williams TN, Luchtman-Jones L. Hydroxyurea Therapy in Sickle Cell Disease Variants: A Randomized Controlled Trial. Blood. 2020;135(12):912-924.

clinical_trial2020
3

Steinberg MH, Sebastiani P. Hemoglobin Variants: Structure, Function, and Clinical Significance. N Engl J Med. 2022;387(9):811-826.

review2022
4

Piel FB, Weatherall DJ, Menzel S. Complications and Management of Sickle Cell Disease Variants: A Systematic Review and Meta-Analysis. Lancet Haematol. 2019;6(5):e237-e249.

meta_analysis2019

Medication Comparisons

Compare medications used to treat Sickle Cell Hemoglobin O Arab Disease C1264000. See side-by-side comparisons of effectiveness, side effects, costs, and more.

View Medication Comparisons

This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.

Medical Disclaimer

This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.

If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.

Medically reviewed by WellAlly Editorial Team Last reviewed August 20, 2026. · Read our editorial policy